Search research articles
Contact Us
Filters
Showing results (101-110 of 133) with videos related to
Page
of 14
Sort By:
Leukemia Research
|
June 18, 2021
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy
Anthony M Hunter, Najla Al Ali, Anne Mai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 15, 2021
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies
Quinto J Gesiotto, David M Swoboda, Rory M Shallis, et al.
American Journal of Hematology
|
February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2021
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
Rory M Shallis, Jan Philipp Bewersdorf, David M Swoboda, et al.
Molecular Cell
|
April 3, 2026
U2AF regulates the translation and localization of nuclear-encoded mitochondrial mRNAs
Gloria R Garcia, Murali Palangat, Josquin Moraly, et al.
American Journal of Hematology
|
January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Daniel R Richardson, David M Swoboda, Dominic T Moore, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 25, 2022
Corrigendum to 'BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression' European Neuropsychopharmacology Volume 58, May 2022, Pages 103-108
Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 22, 2022
BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology
Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, et al.
Translational Behavioral Medicine
|
April 13, 2012
Integrating eHealth With Human Services for Breast Cancer Patients
Robert P Hawkins, Suzanne Pingree, Timothy Baker, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 133) with videos related to
Sort By:
Page
of 14
Leukemia Research
|
June 18, 2021
Leukocytosis is associated with end organ damage and mortality in chronic myelomonocytic leukemia and can be mitigated by cytoreductive therapy
Anthony M Hunter, Najla Al Ali, Anne Mai, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 15, 2021
Evaluating Predictors of Immune-Related Adverse Events and Response to Checkpoint Inhibitors in Myeloid Malignancies
Quinto J Gesiotto, David M Swoboda, Rory M Shallis, et al.
American Journal of Hematology
|
February 18, 2022
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better?
Somedeb Ball, Akriti G Jain, Luis E Aguirre, et al.
Hematological Oncology
|
May 16, 2026
Extended Versus Standard Hypomethylating Agent Dosing in Combination With Venetoclax in Patients With Newly Diagnosed Acute Myeloid Leukemia
Georgio Medawar, Jean-Sebastien Anoma, Elizabeth Hill, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 8, 2021
Challenges in the Evaluation and Management of Toxicities Arising From Immune Checkpoint Inhibitor Therapy for Patients With Myeloid Malignancies
Rory M Shallis, Jan Philipp Bewersdorf, David M Swoboda, et al.
Molecular Cell
|
April 3, 2026
U2AF regulates the translation and localization of nuclear-encoded mitochondrial mRNAs
Gloria R Garcia, Murali Palangat, Josquin Moraly, et al.
American Journal of Hematology
|
January 27, 2021
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia
Daniel R Richardson, David M Swoboda, Dominic T Moore, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
June 25, 2022
Corrigendum to 'BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression' European Neuropsychopharmacology Volume 58, May 2022, Pages 103-108
Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 22, 2022
BDNF gene polymorphisms predicting treatment response to CBT-based rehabilitation of depression: to be submitted to: European Neuropsychopharmacology
Alexandra Schosser, Daniela Fischer-Hansal, Marleen M Swoboda, et al.
Translational Behavioral Medicine
|
April 13, 2012
Integrating eHealth With Human Services for Breast Cancer Patients
Robert P Hawkins, Suzanne Pingree, Timothy Baker, et al.
Page
of 14